DoW Pancreatic Cancer Research Program, Focused Pilot Award
This grant funds innovative, patient-focused pancreatic cancer research projects that generate strong preliminary data for future clinical application, excluding clinical trials and preclinical animal studies.
Funder: Dept. of the Army -- USAMRAA
Due Dates: September 16, 2026 (Pre-Application/LOI) | October 7, 2026 (Full Application) | October 13, 2026 (Application Verification)
Funding Amounts: ~$1.2M total for ~4 awards; up to $300,000 total costs per award over 2 years
Summary: Supports innovative, patient-centered research in pancreatic cancer to generate preliminary data for future clinical or real-world studies; clinical trials and preclinical animal studies are not allowed.
Key Information: Pre-application (LOI) via eBRAP is required; full application via Grants.gov or eBRAP (intramural only).
Description
This award supports the exploration and development of impactful, innovative concepts in patient-centered pancreatic cancer research. The aim is to produce robust preliminary data that can serve as the foundation for future clinical or real-world research applications, with a strong emphasis on improving patient quality of life. The mechanism allows but does not require preliminary data, and encourages studies such as observational clinical research, behavioral studies, and analyses of existing data. Clinical trials and preclinical animal studies are not permitted under this funding opportunity.
